Diff of /README.md [000000] .. [c64c2b]

Switch to unified view

a b/README.md
1
<h1>Summary Statistics: Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases</h1>
2
3
<h2>Creators</h2>
4
<ul>
5
  <li>Mitchell, Jonathan</li>
6
</ul>
7
8
<h2>Contributors</h2>
9
<p>Researchers:</p>
10
<ul>
11
  <li>Camacho, Niedzica</li>
12
  <li>Shea, Patrick</li>
13
  <li>Stopsack, Konrad</li>
14
  <li>Joseph, Vijai</li>
15
  <li>Burren, Oliver</li>
16
  <li>Dhindsa, Ryan</li>
17
  <li>Nag, Abhishek</li>
18
  <li>Berchuck, Jacob</li>
19
  <li>O'Neill, Amanda</li>
20
  <li>Abbasi, Ali</li>
21
  <li>Zoghbi, Anthony</li>
22
  <li>Alegre-Díaz, Jesus</li>
23
  <li>Kuri-Morales, Pablo</li>
24
  <li>Berumen, Jaime</li>
25
  <li>Tapia-Conyer, Roberto</li>
26
  <li>Emberson, Jonathan</li>
27
  <li>Torres, Jason</li>
28
  <li>Collins, Rory</li>
29
  <li>Wang, Quanli</li>
30
  <li>Goldstein, David</li>
31
  <li>Matakidou, Athena</li>
32
  <li>Haefliger, Carolina</li>
33
  <li>Anderson-Dring, Lauren</li>
34
  <li>March, Ruth</li>
35
  <li>Jobanputra, Vaidehi</li>
36
  <li>Dougherty, Brian</li>
37
  <li>Carss, Keren</li>
38
  <li>Petrovski, Slavé</li>
39
  <li>Kantoff, Philip</li>
40
  <li>Offit, Kenneth</li>
41
  <li>Mucci, Lorelei</li>
42
  <li>Pomerantz, Mark</li>
43
  <li>Fabre, Margarete</li>
44
</ul>
45
46
<h2>Description</h2>
47
<p>Exome-wide gene and single variant level summary statistics associated with the Nature Communications article "<i>Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases</i>".</p>
48
49
<h3>Gene Level Association Files</h3>
50
<ul>
51
  <li><strong>gene_level_prostate_cancer_risk.txt</strong>: Gene-level summary statistics for association with prostate cancer risk (case vs controls)</li>
52
  <li><strong>gene_level_prostate_cancer_severity.txt</strong>: Gene-level summary statistics for association with prostate cancer severity (aggressive prostate cancer vs non-aggressive prostate cancer)</li>
53
  <li><strong>gene_level_prostate_cancer_agg_ctrl.txt</strong>: Gene-level summary statistics for association of aggressive prostate cancer vs controls</li>
54
</ul>
55
56
<h4>Columns</h4>
57
<ul>
58
  <li>Gene Name</li>
59
  <li>Gene ENSG - Ensembl gene ID</li>
60
  <li>CA_model - collapsing analysis qualifying variant model (as in Supplementary Data 1 of article)</li>
61
  <li>CMH_P - meta analysis P-value</li>
62
  <li>CMH_OR - meta analysis odds ratio</li>
63
  <li>CMH_OR_LCI - meta analysis odds ratio lower confidence interval</li>
64
  <li>CMH_OR_UCI - meta analysis odds ratio upper confidence interval</li>
65
  <li>Total Qual Cases - number of cases carrying a qualifying variant</li>
66
  <li>Total Unqual Cases - number of cases not carrying a qualifying variant</li>
67
  <li>Total Qual Ctrls - number of controls carrying a qualifying variant</li>
68
  <li>Total Unqual Ctrls - number of controls not carrying a qualifying variant</li>
69
</ul>
70
71
<h3>Single Variant Level Association File</h3>
72
<ul>
73
  <li><strong>single_variant_prostate_cancer_risk.txt</strong>: Single variant level summary statistics for association with prostate cancer risk (case vs controls)</li>
74
</ul>
75
76
<h4>Columns</h4>
77
<ul>
78
  <li>chr - chromosome</li>
79
  <li>pos - genomic position</li>
80
  <li>effect_allele</li>
81
  <li>other_allele</li>
82
  <li>P - meta analysis P-value</li>
83
  <li>direction - direction of effect in individual cohorts (100KGP, MCPS, UKB_SAS, UKB_AFR, UKB_EUR, FinnGen)</li>
84
</ul>